| 1 |
34260908 |
10.1016/j.celrep.2021.109372 |
2021 |
Inhibition of Rag GTPase signaling in mice suppresses B cell responses and lymphomagenesis with minimal detrimental trade-offs. |
RRAGC |
| 2 |
31579886 |
10.1038/s42255-019-0098-8 |
2019 |
Oncogenic Rag GTPase signaling enhances B cell activation and drives follicular lymphoma sensitive to pharmacological inhibition of mTOR. |
RRAGC |
| 3 |
28659443 |
10.1126/scitranslmed.aak9969 |
2017 |
Genetic and epigenetic inactivation of <i>SESTRIN1</i> controls mTORC1 and response to EZH2 inhibition in follicular lymphoma. |
RRAGC |
| 4 |
26691987 |
10.1038/ng.3473 |
2016 |
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma. |
RRAGC |
| 5 |
27230687 |
10.1038/ng0616-700b |
2016 |
Corrigendum: Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma. |
RRAGC |
| 6 |
27267853 |
10.1158/1078-0432.CCR-16-0609 |
2016 |
Recurrent Mutations in the MTOR Regulator RRAGC in Follicular Lymphoma. |
RRAGC |
Datasets
Models
